We produce a comprehensive, diverse and highly complementary portfolio of specialty and generic products targeting a wide spectrum of chronic and acute treatments. Our manufacturing capabilities span generics, branded generics, difficult-to-make technology intensive products, over-the-counter (OTC), anti-retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and intermediates. Our presence in more than 150 countries helps us in being responsive to local treatment needs while continually improving our global product offering.
Our products have the hallmark of technology-based differentiation and cover the full range of dosage forms, including tablets, capsules, injectables, inhalers, ointments, creams and liquids. The therapeutic segments covered by our portfolio of over 3000 high quality molecules include psychiatry, anti-infectives, neurology, cardiology, orthopaedic, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental and nutritionals. In several countries, Sun Pharma ranks among the leading companies in these therapy areas.
We remain committed to providing affordable pharmaceutical products of global quality standards to patients all over the world.
Click here to view our list of products in India.